239 related articles for article (PubMed ID: 3059653)
21. Oncogenes, growth factors, and prognostic indicators in colorectal cancer.
Rowley S; Newbold M; Neoptolemos JP
Surg Annu; 1992; 24 Pt 2():59-85. PubMed ID: 1440150
[No Abstract] [Full Text] [Related]
22. Oncogenes and uterine function.
Stancel GM; Baker VV; Hyder SM; Kirkland JL; Loose-Mitchell DS
Oxf Rev Reprod Biol; 1993; 15():1-42. PubMed ID: 8336974
[No Abstract] [Full Text] [Related]
23. Recent advances in the molecular genetics of urogenital tumors.
Yoshida O; Habuchi T; Ogawa O
Int J Urol; 1994 Mar; 1(1):1-16. PubMed ID: 7627831
[No Abstract] [Full Text] [Related]
24. Signalling to chromatin and the superinduction of proto-oncogenes.
Zhelev N; Kardalinou E; Hazzalin CA; Cano E; Barratt MJ; Mahadevan LC
Biochem Soc Trans; 1993 Nov; 21(4):907-11. PubMed ID: 8132091
[No Abstract] [Full Text] [Related]
25. Oncogenes, onco-suppressors, carcinogenesis and oral cancer.
Scully C
Br Dent J; 1992 Jul; 173(2):53-9. PubMed ID: 1386990
[TBL] [Abstract][Full Text] [Related]
26. Scatter factor and its relationship to hepatocyte growth factor and met.
Rosen EM; Knesel J; Goldberg ID
Cell Growth Differ; 1991 Nov; 2(11):603-7. PubMed ID: 1839956
[No Abstract] [Full Text] [Related]
27. Oncogenes: cause or consequence in the development of glial tumors.
Akbasak A; Sunar-Akbasak B
J Neurol Sci; 1992 Sep; 111(2):119-33. PubMed ID: 1331337
[TBL] [Abstract][Full Text] [Related]
28. Growth factor-mediated proliferative pathways and the neoplastic process.
Cheah MS; Igarashi H; Leal F; Naharro G; Robbins KC
Cancer Invest; 1986; 4(4):329-41. PubMed ID: 3021293
[No Abstract] [Full Text] [Related]
29. Suppressor screening -- a potential new model for understanding the genetic components of urological malignancies.
Kommu S
BJU Int; 2004 Oct; 94(6):759-60. PubMed ID: 15476503
[No Abstract] [Full Text] [Related]
30. Potential oncogenic hazards posed by oncogene encoded proteins.
Lowy DR
Dev Biol Stand; 1987; 68():63-7. PubMed ID: 3319740
[TBL] [Abstract][Full Text] [Related]
31. Out of control. Molecular Aspects of Growth Control sponsored by the Japanese Cancer Association and the American Association for Cancer Research, Honolulu, HI, USA, May 28-31, 1989.
Cross SL
New Biol; 1989 Nov; 1(2):137-40. PubMed ID: 2577366
[No Abstract] [Full Text] [Related]
32. Proto-oncogenes in cell differentiation.
Zelenka PS
Bioessays; 1990 Jan; 12(1):22-6. PubMed ID: 2157400
[TBL] [Abstract][Full Text] [Related]
33. [Proto-oncogenes and the control of cell growth].
Lehväslaiho H; Mäkelä TP; Alitalo K
Duodecim; 1990; 106(3):261-77. PubMed ID: 1670091
[No Abstract] [Full Text] [Related]
34. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
35. Human proto-oncogenes, growth factors, and cancer.
Aaronson SA; Robbins KC; Tronick SR
Symp Fundam Cancer Res; 1984; 37():241-55. PubMed ID: 6396789
[No Abstract] [Full Text] [Related]
36. The role of hematopoietic growth factors and oncogenes in leukemogenesis.
Kastan MB; Strauss LC; Civin CI
Am J Pediatr Hematol Oncol; 1989; 11(3):249-67. PubMed ID: 2675658
[TBL] [Abstract][Full Text] [Related]
37. Molecular biology of genitourinary cancer.
Ackermann R; Schmitz-Dräger BJ
World J Urol; 1994; 12(2):63. PubMed ID: 8087141
[No Abstract] [Full Text] [Related]
38. Non-nuclear oncogenes and the regulation of gene expression in transformed cells.
Bortner DM; Langer SJ; Ostrowski MC
Crit Rev Oncog; 1993; 4(2):137-60. PubMed ID: 8380545
[TBL] [Abstract][Full Text] [Related]
39. raf family serine/threonine protein kinases in mitogen signal transduction.
Rapp UR; Heidecker G; Huleihel M; Cleveland JL; Choi WC; Pawson T; Ihle JN; Anderson WB
Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 1():173-84. PubMed ID: 2978288
[No Abstract] [Full Text] [Related]
40. Growth factor receptors and cell transformation.
Sherr CJ
Mol Biol Med; 1987 Feb; 4(1):1-10. PubMed ID: 3039289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
